Fully remote versus hybrid supervision of pulmonary telerehabilitation in COVID-19: a randomized clinical trial

被引:0
|
作者
Vian, Bruna S. [1 ,2 ]
Ratti, Ligia S. [1 ]
Resende, Mariangela R. [3 ]
Conterno, Lucieni de O. [3 ]
Pereira, Monica C. [2 ]
机构
[1] Univ Estadual Campinas, Univ Hosp, Physiotherapy & Occupat Therapy Serv, Campinas, Brazil
[2] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Div Pneumol, Campinas, Brazil
[3] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Div Infectivol, Campinas, Brazil
基金
巴西圣保罗研究基金会;
关键词
Telerehabilitation; COVID-19; Walk test; Quality of life; 6-MINUTE WALK; STATEMENT; DISEASE; REHABILITATION; ADULTS; TESTS;
D O I
10.23736/S1973-9087.24.08634-9
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
BACKGROUND: The restrictions imposed by the COVID-19 pandemic have impeded the traditional rehabilitation process, prompting the widespread adoption of remote programs for the recovery of survivors. AIM: The aim of this study was to evaluate and compare the effectiveness of a pulmonary telerehabilitation program (PTRP) in the exclusively remote modality versus the hybrid modality (remote and face-to-face) in patients with persistent respiratory dysfunction following hospitalization for COVID-19 pneumonia, and to compare the functional capacity of patients who participated in a PTRP with those who did not. DESIGN: A randomised, interventional, prospective clinical trial was conducted. In parallel, an observational cohort study was conducted. SETTING: Outpatient rehabilitation clinic and home-based rehabilitation program. POPULATION: Thirty patients post-COVID-19 were randomised into two groups: G1 (fully remote supervision of PTRP) or G2 (hybrid supervision of PTRP). Thirty-seven post-COVID-19 patients were followed up without participating in PTRP (non-intervention group- NIG). METHODS: Patients with persistent respiratory dysfunction and reduced functional capacity, as measured by the Six Minute Walk Test (6MWT), after hospitalization for COVID-19 pneumonia, were considered eligible for a PTRP. To assess the efficacy of the PTRP, the primary outcome (I) was distance walked on the 6MWT (6MWD) and the secondary outcome (II) was quality of life as assessed by the SF-36 questionnaire. RESULTS: Both G1 and G2 demonstrated similar improvement in 6MWD, P<0.001 and quality of life (P<0.05). The IG showed higher 6MWD than the NIG (P<0.001). The increase in 6MWD for the IG was 140.5 m, while for the NIG it was 16.8 m (P=0.002). CONCLUSIONS: The PTRP was found to be a feasible and highly effective intervention for restoring functional capacity and improving quality of life, regardless of the type of supervision. Furthermore, this functional gain was maintained over the long term. In patients with pulmonary dysfunction, participation in the PTRP improved functional capacity compared with those who were simply advised to resume physical activity during recovery. CLINICAL REHABILITATION IMPACT: Telerehabilitation has been demonstrated to be a viable and efficacious alternative to traditional inperson programs in low-income contexts.
引用
收藏
页码:141 / 153
页数:13
相关论文
共 50 条
  • [21] SUBPHENOTYPES IN COVID-19 ARDS: SECONDARY ANALYSIS OF A RANDOMIZED CLINICAL TRIAL
    Kast, Rachel
    Bulgarelli, Lucas
    Van Ark, Emily
    Osborn, Jeff
    Rey, Diego
    Siuba, Matthew
    Duggal, Abhijit
    Tomazini, Bruno
    Bueno, Flavia
    Biasi, Alexandre
    Sampaio, Camila
    Olivato, Guilherme
    Pereira, Adriano
    Dal-Pizzol, Felipe
    Azevedo, Luciano
    Neto, Ary Serpa
    Deliberato, Rodrigo
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 126 - 126
  • [22] Thalidomide for the treatment of COVID-19 pneumonia: A randomized controlled clinical trial
    Amra, Babak
    Ashrafi, Farzaneh
    Torki, Mehdi
    Hashemi, Marzieh
    Shirzadi, Mohamad
    Soltaninejad, Forogh
    Sadeghi, Somayeh
    Salmasi, Mehrzad
    Sami, Ramin
    Darakhshandeh, Ali
    Nasirian, Maryam
    Pourajam, Samaneh
    ADVANCED BIOMEDICAL RESEARCH, 2023, 12 (01): : 14
  • [23] Hydroxychloroquine for prophylaxis of COVID-19 in health workers: A randomized clinical trial
    Rojas-Serrano, Jorge
    Portillo-Vasquez, Angelica Margarita
    Thirion-Romero, Ireri
    Vazquez-Perez, Joel
    Mejia-Nepomuceno, Fidencio
    Ramirez-Venegas, Alejandra
    Perez-Kawabe, Karla Midori
    Perez-Padilla, Rogelio
    PLOS ONE, 2022, 17 (02):
  • [24] Impact of COVID-19 on a Pragmatic, Cluster Randomized Clinical Trial for Fibromyalgia
    Bayman, Emine O.
    Dailey, Dana
    Ecklund, Dixie
    Johnson, Elizabeth M.
    Vance, Carol G. T.
    Zimmerman, Bridget
    Costigan, Michele
    Chimenti, Ruth
    Spencer, Maggie
    Post, Andrew
    Huff, Trevis
    Koepp, Maxine
    Archer, Kristin R.
    Peters, Rick
    Nye, George
    Franck, Carla
    Neill-Hudson, Tina
    Crofford, Leslie
    Sluka, Kathleen
    JOURNAL OF PAIN, 2021, 22 (05): : 586 - 586
  • [25] Telmisartan for treatment of Covid-19 patients: an open randomized clinical trial
    Duarte, M.
    Pelorosso, F.
    Nicolosi, L. N.
    Salgado, V.
    Vetulli, H. M.
    Arquieri, A.
    Azzato, F.
    Coyle, J.
    Davolos, I.
    Fernandez Criado, I.
    Gregori, R.
    Rubio, M. C.
    Sarquis, S. M.
    Whalmann, F.
    Rothlin, R. P.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2965 - 2965
  • [26] Implementation of a fully remote randomized clinical trial with cardiac monitoring
    Mayfield, Jacob J.
    Chatterjee, Neal A.
    Noseworthy, Peter A.
    Poole, Jeanne E.
    Ackerman, Michael J.
    Stewart, Jenell
    Kissinger, Patricia J.
    Dwyer, John
    Hosek, Sybil
    Oyedele, Temitope
    Paasche-Orlow, Michael K.
    Paolino, Kristopher
    Friedman, Paul A.
    Waters, Chloe
    Moreno, Jessica
    Leingang, Hannah
    Heller, Kate B.
    Morrison, Susan A.
    Krows, Meighan L.
    Barnabas, Ruanne V.
    Baeten, Jared
    Johnston, Christine
    Sridhar, Arun R.
    COMMUNICATIONS MEDICINE, 2021, 1 (01):
  • [27] Implementation of a fully remote randomized clinical trial with cardiac monitoring
    Jacob J. Mayfield
    Neal A. Chatterjee
    Peter A. Noseworthy
    Jeanne E. Poole
    Michael J. Ackerman
    Jenell Stewart
    Patricia J. Kissinger
    John Dwyer
    Sybil Hosek
    Temitope Oyedele
    Michael K. Paasche-Orlow
    Kristopher Paolino
    Paul A. Friedman
    Chloe Waters
    Jessica Moreno
    Hannah Leingang
    Kate B. Heller
    Susan A. Morrison
    Meighan L. Krows
    Ruanne V. Barnabas
    Jared Baeten
    Christine Johnston
    Arun R. Sridhar
    Communications Medicine, 1
  • [28] A Comparison of Recruitment Methods for a Remote, Nationwide Clinical Trial for COVID-19 Treatment
    Hartman, Katrina M.
    Patel, Barkha
    Rao, Via
    Hagen, Aubrey A.
    Saveraid, Hanna G.
    Fricton, Regina
    Lee, Samuel
    Snyder, Andrew T.
    Pullen, Matthew F.
    Boulware, David R.
    Liebovitz, David M.
    Belani, Hrishikesh K.
    Niklas, Jacinda M.
    Murray, Thomas A.
    Cohen, Ken
    Thompson, Jennifer L.
    Erickson, Spencer M.
    Bramante, Carolyn T.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (07):
  • [29] The COVID-19 Pandemic and Probation in Chile: Remote Supervision and Regional Differences
    Sebastián Galleguillos
    Mauricio Sánchez Cea
    Deborah Koetzle
    Jeff Mellow
    Diego Piñol Arriagada
    Craig Schwalbe
    International Criminology, 2022, 2 (1): : 70 - 83
  • [30] Efficacy and Safety of Atazanavir/Ritonavir Versus Lopinavir/Ritonavir in Hospitalized COVID-19 Patients: A Randomized Clinical Trial
    Siami, Zeinab
    Dehghan, Danial
    Khavandegar, Armin
    Lak, Mehran
    Bakhtiyari, Mahmood
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2022, 24 (05)